Cite
HARVARD Citation
Dall'Olio, F. et al. (2021). Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non–small cell lung cancer treated with first-line pembrolizumab. European journal of cancer. pp. 99-107. [Online].